Making A Difference
Zerodha co-founder Nikhil Kamath and Kiran Mazumdar-Shaw, who is the executive chairperson of Biocon and Biocon Logistics, have announced a whopping donation of Rs 50 lakhs to charity.
Kamath announced the philanthropic act on his podcast, “NK Talks: The Nikhil Kamath Show," where Mazumdar-Shaw was a guest.
“In this episode, Kiran and I together are grateful to be able to contribute 50 lakhs to charity!" he announced in a Instagram post.
The charity will be democratically decided based on the number of votes suggested by users in the podcast's YouTube comments section. “Your voice matters, and every vote matters. The charity with the most votes wins democratically. So please join us. Let's show the world the power of unity in making a difference," he said.
Zerodha's co-founders, Nithin Kamath and his brother Nikhil Kamath, have recently been included in the Forbes World's Billionaire list of 2023. Nithin Kamath is ranked 1,104th on the list, with an estimated net worth of $2.7 billion. Nikhil Kamath, who serves as Zerodha's Chief Financial Officer, has a net worth of $1.1 billion and is ranked 2,405th on the list.
Meanwhile, Kiran Mazumdar-Shaw was listed in Forbes World's 100 Most Powerful Women list in 2021. In 1978, Mazumdar-Shaw, India's richest self-made woman, founded India's largest listed biopharmaceutical firm by revenue. The company has successfully entered the lucrative US biosimilars market, attracting investors' attention. To date, the firm has sold 3 billion doses of insulin and operates Asia's largest insulin factory in Malaysia's Johor region.
Biocon is collaborating with US firm Adagio Therapeutics to develop ADG20, an antibody therapy for preventing and treating the Coronavirus and its variants. In September 2021, vaccine billionaire Cyrus Poonawalla's Serum Institute of India agreed to acquire a 15% stake in Biocon Biologics, a subsidiary of Biocon.
Related Posts: BIOCON,CHARITY,DONATION,KIRAN MAZUMDAR SHAW,NIKHIL KAMATH,PODCAST,ZERODHA
Biocon ropes in Peter Bains as group CEO
Biotechnology major Biocon Ldt, on Monday, appointed its Board of Director member, Peter Bains, as its new group Chief Executive Officer.
To takeover the position, Peter Bains, stepped down from his role as non-executive independent director from the Board of Biocon Ltd with with immediate effect.
“Consequently, he has also ceased to be a member of the audit committee, risk management committee and stakeholders relationship committee of the company," said the company in its stock exchange filing.
About Peter Bains
He has over 30 years of experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on the Board of Syngene International Ltd, a subsidiary of the company, for almost 6 years from 2010, and led the company to its successful public listing in 2015, Biocon said.
During his tenure in Syngene, he took the firm through its IPO in 2015. He had also served as CEO of Sosei Group, which is a Japanese-listed biopharmaceutical company. Before taking the position, Peter had also worked with GlaxoSmithKline over a period of 23 years. During his tenure in the company he held several roles, including head of global marketing and senior vice-president of commercial development for GSK's International region.
Currently, Peter Bains also served as the non-executive director on the Board of Indivior PLC, a UK FTSE listed pharmaceuticals company, MiNA Therapeutics, a privately held UK biotech company, and non-executive Chairman of ILC Therapeutics.
Source: Live Mint
Related Posts: BIOCON,PETER BAINS,CEO,KIRAN MAZUMDAR SHAW
Battling social media addiction
In the world of social media, where we constantly scroll apps for hours, and affecting our mental health, brokerage firm Zerodha's founder Nithin Kamath has shared tips to cut down this addiction and live a more peaceful life.
Since the arrival of apps like Facebook, Twitter, Instagram, and Snapchat, the urge to receive 'maximum' likes and 'positive' comments has become a big distraction in everyday life. Besides, the constant need for dopamine hits from likes and shares triggers to post things even when there is nothing to share. And if a post doesn't get activity, people don't feel good as ‘we consciously or subconsciously compare ourselves to others all the time', Kamath said.
Henceforth, sharing some powerful tips on how to overcome from social media addiction, the Zerodha founder wrote a post on the X platform.
Kamath wrote, "Being on social media and fighting all these urges and triggers is one of the most challenging things I have done".
Kamath added that Bhuvan from Zerodha online helped him to beat the social media addiction. As per Kamath's long post on how to de-addict yourself from social media, he followed simple rules such as --no tracking of comments, not engaging with anyone online, using social media only for 30 minutes per day, and avoiding consuming the content on the social media platform.
"What seems to be helping me is to have Bhuvan with the power to kill all my posts and try not to go in the rabbit hole of tracking comments and not engage with anyone online".
"Also, having a time limit of 30 minutes per day and avoiding consuming the content the social media platform algorithms push stops me from that default reaction of scrolling down to see more" Kamath added.
Source: Live Mint
Related Posts: ZERODHA,SOCIAL MEDIA,SOCIAL MEDIA ADDICTION,SOCIAL MEDIA MENTAL HEALTH,HOW SOCIAL MEDIA IMPACTING HEALTH,SOCIAL MEDIA NEWS,NITHIN KAMATH
Zerodha Gets Final Approval For Mutual Fund Business
Online brokerage Zerodha has got the final approval for its mutual fund business, Zerodha Fund House, which will be established in partnership with Small Case, said Zerodha founder and CEO Nithin Kamath. Industry veteran Vishal Jain will be the new CEO of the AMC business.
In April, both Zerodha and Smallcase announced that they would set up a joint venture to launch the Zerodha AMC business.
“We just received the final approval for the @ZerodhaAMC we are building in partnership with @smallcaseHQ," said Kamath on Friday evening on the X platform, formerly known as Twitter.
He said his motivation to start a mutual fund was twofold. The first was that the biggest challenge and opportunity for Indian markets is the shallow participation. He said that even after all the growth over the past three years, there are maybe 6-8 crore unique mutual fund and equity investors put together.
“The second was that if we had to bring in the next 10 million investors, they needed simple products they could understand, and mutual funds were a perfect instrument. We aim to be index-only and create simple funds and ETFs that all investors can understand and invest in for all their goals," Nithin Kamath said.
Vishal Jain, who has been part of the entire passive investing journey in India from Day 1, has joined us as a chief executive officer (CEO) to build the asset management company (AMC). “So yeah, keep an eye out for our first NFO (new fund offer)," Kamath said.
On Thursday, Helios Capital also received Sebi's approval to launch a mutual fund business. Old Bridge Capital Management Pvt Ltd is awaiting Sebi's final nod for a mutual fund licence. Besides, applications of three companies — Unifi Capital Pvt Ltd, Alpha Alternatives Fund Advisors LLP and Wizemarkets Analytics Pvt Ltd — are under the regulator's consideration as of June 2023, data with Sebi showed.
The Securities and Exchange Board of India (SEBI) had given in-principle approval to Zerodha in 2021 for its mutual fund application.
Sequoia-backed smallcase offers people a chance to invest in the stock market through portfolios of stocks or exchange-traded funds (ETFs). The company had earlier collaborated with Zerodha for thematic investment in 2016. The thematic investments included portfolios holding between 10-20 stocks. The themes were based on long term trends, policy reforms by the government, sectoral shifts, technology, demographics and culture.
Related Posts: MUTUAL FUND,ZERODHA
Zerodha Users Can Now Trade Options On Sensibull For Free Published 12 hours ago
Zerodha-Sensibull deal: Sensibull CEO and co-founder Abid Hassan on Monday announced that options trading on the platform will be completely free for all Zerodha users from Monday, July 24, 2023. Under the deal, Zerodha will be paying for this Sensibull facility and users will not be charged anything for this.
“This is the biggest and the most exciting news since we started Sensibull in 2017. Starting today, Sensibull will be 100 per cent free for all Zerodha users, forever," Hassan said in a tweet on Monday.
He added that users get access to the country's best options trading platform for free, Zerodha gives their options traders the best user experience, and we get paid too as a business. “Everyone wins!"
Zerodha founder and CEO Nithin Kamath said in a tweet, “We have good news for all @zerodhaonline option traders, @BeSensibull will now be completely free. We cover the costs so that @abidsensibull & Team can focus on only one thing: Help option traders do better."
Abid Hassan said Sensibull does not have to think of making a yearly profit from subscriptions or selling more of its product. It only has one mission - Improve the lives of traders, try to make them profitable, and do what is truly good for our users.
For trading, users have to pay the normal charges that they pay Zerodha — Rs 20 per order — whether they trade from Kite, or directly from Sensibull. “Long story short, no extra charges for using Sensibull," Hassan said.
“Please give us relentless feedback and criticism. Just because we are free, it does not mean you do not have a right to complain. We would not have been here without your feedback and criticism. Most of Sensibull was built with customer feedback. Some of our best features were designed by our users. So please continue doing that, and help us make Sensibull better. Please complain, criticize, and give us your valuable feedback and suggestions on email@example.com or our social media channels," Hassan said in the tweet.
He added that lease spread the word - There is absolutely no reason why anyone should use anything else now that Sensibull is free. Our tech infrastructure is the best of all options platforms in India. “Our math is by far the most accurate. And most of the UI on other platforms is copy pasted from us anyway. The Original is always better".
Related Posts: ZERODHA,OPTIONS